A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes
Primary Purpose
Weight Loss, Obesity, Diabetes
Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Weight loss interventional study with a low-calorie 18%-protein diet
Weight loss interventional study with a low-calorie 35%-protein diet
Sponsored by
About this trial
This is an interventional treatment trial for Weight Loss
Eligibility Criteria
Inclusion Criteria:
- Age: 18-70 years old.
- Body mass index between 27.5 - 40.
- Steady weight (± 4 kg) in the last 2 months.
- Glycated hemoglobin between 6 - 7%.
Exclusion Criteria:
- Anti-diabetic drugs (oral or subcutaneous) in the last 2 months.
- Lipid-lowering drugs in the last 2 months.
- Gouty arthritis in the last 2 years or uric acid > 735 mg/dl.
- Presence of uncontrolled endocrinological pathology (including hypothyroidism).
- Hepatic chronic disease (glomerular filtration rate < 45 ml/min).
- Renal, inflammatory or tumoral diseases.
- Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy.
- Intake of functional foods with plant sterols in the past 6 weeks.
- High alcohol intake (> 30 g per day).
- Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study.
- Pregnancy or intention of pregnancy during the study.
Sites / Locations
- Fernando CiveiraRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
18%-Protein diet
35%-Protein diet
Arm Description
Energy-restricted diet wit the following composition: 18% protein, 30% fat and 52% carbohydrates
Energy-restricted diet wit the following composition: 35% protein, 30% fat and 35% carbohydrates
Outcomes
Primary Outcome Measures
Change in glucose.
Change in glycated hemoglobin.
Change in insulin resistance (HOMA index).
Secondary Outcome Measures
Change in body weight.
Change in body composition.
Change in waist circumference.
Change in lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, non HDL cholesterol, triglycerides and apolipoproteins).
Full Information
NCT ID
NCT02559479
First Posted
September 22, 2015
Last Updated
December 1, 2016
Sponsor
Instituto Aragones de Ciencias de la Salud
1. Study Identification
Unique Protocol Identification Number
NCT02559479
Brief Title
A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes
Official Title
A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes
Study Type
Interventional
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Unknown status
Study Start Date
September 2015 (undefined)
Primary Completion Date
June 2017 (Anticipated)
Study Completion Date
June 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instituto Aragones de Ciencias de la Salud
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of the study is to assess the effect of low-calorie diets with normal (18%) vs. high (35%) protein (mainly coming from animal source) composition on body weight and carbohydrates metabolism in overweight and obese subjects with pre-diabetes or diabetes. A dietary intervention is carried out during 6 months in 100 subjects who are individually randomized to an energy-restricted diet with two types of macronutrients composition: 1) 35% protein, 30% fat and 35% carbohydrates and 2) 18% protein, 30% fat and 52% carbohydrates. Around 80% of total protein in diet comes from animal source (of whom around 40% from lean red meat). Subjects are provided with weekly menus and different recipes to use them as part of the diet. Monitoring visits with the nutritionist will be performed every 15 days. At the beginning of the study, after 3 and 6 months, the following parameters are determined: anthropometric (weight, waist circumference, body mass index and body composition), blood pressure, dietary (72-hours dietary registry) and exercise and biochemical analysis (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, apolipoproteins A1 and B, iron, transferring, ferritin, uric acid, glucose, HbA1c, insulin, adiponectin and resistin). Urine samples are also collected to assess microalbuminuria and ureic nitrogen.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Loss, Obesity, Diabetes, Diet, Reducing, Carbohydrates, Protein
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
18%-Protein diet
Arm Type
Active Comparator
Arm Description
Energy-restricted diet wit the following composition: 18% protein, 30% fat and 52% carbohydrates
Arm Title
35%-Protein diet
Arm Type
Active Comparator
Arm Description
Energy-restricted diet wit the following composition: 35% protein, 30% fat and 35% carbohydrates
Intervention Type
Behavioral
Intervention Name(s)
Weight loss interventional study with a low-calorie 18%-protein diet
Intervention Type
Behavioral
Intervention Name(s)
Weight loss interventional study with a low-calorie 35%-protein diet
Primary Outcome Measure Information:
Title
Change in glucose.
Time Frame
After 3 and 6 months of intervention.
Title
Change in glycated hemoglobin.
Time Frame
After 3 and 6 months of intervention.
Title
Change in insulin resistance (HOMA index).
Time Frame
After 3 and 6 months of intervention.
Secondary Outcome Measure Information:
Title
Change in body weight.
Time Frame
After 3 and 6 months of intervention.
Title
Change in body composition.
Time Frame
After 3 and 6 months of intervention.
Title
Change in waist circumference.
Time Frame
After 3 and 6 months of intervention.
Title
Change in lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, non HDL cholesterol, triglycerides and apolipoproteins).
Time Frame
After 3 and 6 months of intervention.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age: 18-70 years old.
Body mass index between 27.5 - 40.
Steady weight (± 4 kg) in the last 2 months.
Glycated hemoglobin between 6 - 7%.
Exclusion Criteria:
Anti-diabetic drugs (oral or subcutaneous) in the last 2 months.
Lipid-lowering drugs in the last 2 months.
Gouty arthritis in the last 2 years or uric acid > 735 mg/dl.
Presence of uncontrolled endocrinological pathology (including hypothyroidism).
Hepatic chronic disease (glomerular filtration rate < 45 ml/min).
Renal, inflammatory or tumoral diseases.
Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy.
Intake of functional foods with plant sterols in the past 6 weeks.
High alcohol intake (> 30 g per day).
Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study.
Pregnancy or intention of pregnancy during the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fernando Civeira, MD, PhD
Phone
+34 976765500
Ext
2884
Email
civeira@unizar.es
First Name & Middle Initial & Last Name or Official Title & Degree
Rocio Mateo-Gallego, RD, PhD
Email
rmateo.iacs@aragon.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando Civeira, MD, PhD
Organizational Affiliation
Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis; Hospital U. Miguel Servet; IIS Aragón
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fernando Civeira
City
Zaragoza
ZIP/Postal Code
50009
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rocio Mateo-Gallego, RD, PhD
Phone
+34 976765500
Ext
2895
Email
rmateo.iacs@aragon.es
First Name & Middle Initial & Last Name & Degree
Victoria Marco-Benedí, RD
Phone
+34 976765500
Ext
2895
Email
vito2911@hotmail.com
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
31255349
Citation
Marco-Benedi V, Perez-Calahorra S, Bea AM, Lamiquiz-Moneo I, Baila-Rueda L, Cenarro A, Civeira F, Mateo-Gallego R. High-protein energy-restricted diets induce greater improvement in glucose homeostasis but not in adipokines comparing to standard-protein diets in early-onset diabetic adults with overweight or obesity. Clin Nutr. 2020 May;39(5):1354-1363. doi: 10.1016/j.clnu.2019.06.005. Epub 2019 Jun 15.
Results Reference
derived
Learn more about this trial
A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes
We'll reach out to this number within 24 hrs